N/A
Completed N=101
Efficacy of T2259 in DED
Dry Eye Syndromes
Source: ClinicalTrials.gov NCT03874429 ↗
Enrolled (actual)
101
Serious AEs
1.0%
Results posted
Nov 2023
Primary outcomePrimary: Surface Ocular Staining With Fluorescein (With Oxford Scale - Ranges : 0-15) — -1.45; -1.79 score on a scale
Summary
The purpose of this study is to compare the performance and safety of T2259 versus Vismed Multi in dry eye patients with superficial keratitis.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Surface Ocular Staining With Fluorescein (With Oxford Scale - Ranges : 0-15) |
-1.45; -1.79 | — |
Eligibility Criteria
Main inclusion Criteria:
- Signed and dated informed consent
- Male or female aged from ≥ 18 years old
- Known Dry Eye Syndrome requiring artificial tears within the last 3 months prior to study selection
Main exclusion Criteria:
- Far best-corrected visual acuity≤2/10
- Severe Blepharitis
Data sourced from ClinicalTrials.gov (NCT03874429). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.